FDA.reportPublic FDA data

Shingles Pain Relief

Product NDC
44911-0334
11-digit product format
449110334
Labeler code
44911
Product ID
44911-0334_1ce2a71f-1c53-4ca6-a20f-253a42690368
Type
HUMAN OTC DRUG
Nonproprietary name
Calendula Officinalis, Croton Tiglium, Natrum Muriaticum, Plantago Major, Rhus Tox, Sarsaparilla (Smilax Regelii)
Dosage form
SPRAY
Route
TOPICAL
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2016-03-23
Marketing end
2025-04-27
Substance
CALENDULA OFFICINALIS FLOWERING TOP; CROTON TIGLIUM SEED; SODIUM CHLORIDE; PLANTAGO MAJOR; TOXICODENDRON PUBESCENS LEAF; SMILAX ORNATA ROOT
Active strength
12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; a/mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct44911-0334DDiscontinued by firm2026-10-05
excluded packagepackage44911-033444911-0334-1DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage44911-0334-1d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage44911-0334-1f5e01cc5f278…a2eaf40c39c3…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0334-12020-04-22C16284748780-19d75b9d0-54ca-f424-e053-dadaa90a57ceDrug Facts:
44911-0334-12020-01-31C16284748780-19d75b9d0-54ca-f424-e053-dadaa90a57ceDrug Facts:

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
44911-0334-14491103340130 mL in 1 BOTTLE, SPRAY (44911-0334-1) 30 ml2016-03-232025-04-27NoNoCurrent